LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | AZD-6482 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 3845 | 5013 | 0.7670 | 0.6844 |
MDA-MB-231 | AZD7762 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 785 | 5013 | 0.1567 | -0.1421 |
MDA-MB-231 | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 1873 | 5013 | 0.3737 | 0.1517 |
MDA-MB-231 | AZD8330 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 1657 | 5013 | 0.3306 | 0.0934 |
MDA-MB-231 | Barasertib | 3.33 | uM | LJP5 | 72 | hr | 1311 | 1607 | 5013 | 0.3207 | 0.0799 |
MDA-MB-231 | BI-2536 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 1296 | 5013 | 0.2586 | -0.0042 |
MDA-MB-231 | BMS345541 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 2458 | 5013 | 0.4903 | 0.3097 |
MDA-MB-231 | SNS-032 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 804 | 5013 | 0.1604 | -0.1371 |
MDA-MB-231 | GDC-0980 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 2148 | 5013 | 0.4285 | 0.2260 |
MDA-MB-231 | NVP-AEW541 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 4780 | 5013 | 0.9535 | 0.9370 |
MDA-MB-231 | SB590885 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 4293 | 5013 | 0.8564 | 0.8055 |
MDA-MB-231 | PIK-93 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 4073 | 5013 | 0.8125 | 0.7461 |
MDA-MB-231 | KIN001-043 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 4481 | 5013 | 0.8938 | 0.8561 |
MDA-MB-231 | Alpelisib | 3.33 | uM | LJP5 | 72 | hr | 1311 | 4556 | 5013 | 0.9089 | 0.8766 |
MDA-MB-231 | Luminespib | 3.33 | uM | LJP5 | 72 | hr | 1311 | 1051 | 5013 | 0.2096 | -0.0704 |
MDA-MB-231 | A443654 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 1131 | 5013 | 0.2257 | -0.0486 |
MDA-MB-231 | OSI-027 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 3146 | 5013 | 0.6276 | 0.4956 |
MDA-MB-231 | XMD11-85h | 3.33 | uM | LJP6 | 72 | hr | 1311 | 4256 | 5013 | 0.8489 | 0.7954 |
MDA-MB-231 | HG-6-64-01 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 1901 | 5013 | 0.3792 | 0.1593 |
MDA-MB-231 | WH-4-025 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 1492 | 5013 | 0.2976 | 0.0487 |
MDA-MB-231 | WZ-4-145 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 4029 | 5013 | 0.8036 | 0.7340 |
MDA-MB-231 | XMD16-144 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 1531 | 5013 | 0.3055 | 0.0594 |
MDA-MB-231 | Brivanib | 3.33 | uM | LJP5 | 72 | hr | 1311 | 5080 | 5013 | 1.0133 | 1.0180 |
MDA-MB-231 | Buparlisib | 3.33 | uM | LJP5 | 72 | hr | 1311 | 1607 | 5013 | 0.3205 | 0.0798 |
MDA-MB-231 | BX-912 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 2012 | 5013 | 0.4014 | 0.1893 |